Pharmaceutical & Healthcare Group
Pharmaceutical
Bel Group, in partnership with leading organizations in South Asia, is committed to improving the health and quality of life for men, women, and children. Together, we develop, produce, and market safe, effective, and high-quality medicines and healthcare products. It is a hub of innovation, this dynamic healthcare and pharmaceutical sector prioritises patient welfare, driving constant evolution. Characterised by strict regulations, technological advancements, and an increase in personalised medicine. The company’s therapeutic segments in the following:
- Analgesic
- Anti-Asthmatic
- Anti-convulsant
- Anti-Diabetic
- Anti-Fibrinolytic
- Anti-Hypertensive
- Anti-Lipidemic
- Anti-Malarial
- Anti-Obesity
- Anti-Rheumatic
- Anti-Ulcertant
- Anti-Viral
- Antibiotic
- Antiallergic
- Gastroprokinetic
- Immunomodulator
- Vitamins and Vitamin Analogue
Healthcare
Bel Group is involved in pre-diagnostic efforts through blood-based biomarkers in collaboration with various partners. Blood-based biomarkers are increasingly used to identify early stages of diseases, providing a minimally invasive method for early diagnosis and monitoring.
- Alzheimer’s Disease: biomarkers such as amyloid-beta (Aβ) peptides and tau proteins in the blood. These biomarkers can indicate the presence of amyloid plaques and neurofibrillary tangles, which are characteristic of Alzheimer’s disease.
- Cancer: Blood-based biomarkers play a crucial role in early cancer detection. Circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and various proteins like CA-125 (ovarian cancer), PSA (prostate cancer), and AFP (liver cancer) are used to identify and monitor different types of cancer.
- Cardiovascular Diseases: Biomarkers such as troponins, B-type natriuretic peptide (BNP), and C-reactive protein (CRP) are essential for diagnosing and assessing the risk of cardiovascular diseases.
- Diabetes: Glycated hemoglobin (HbA1c), is a well biomarker for diagnosing and monitoring diabetes.
- Infectious Diseases: Blood-based biomarkers such as procalcitonin and various cytokines (e.g., IL-6) are used to detect bacterial infections and sepsis. These biomarkers help in differentiating bacterial from viral infections.
- Autoimmune Diseases: rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs) are Biomarkers used for rheumatoid arthritis.
- Global Distribution of high-quality medical in-vitro diagnostic (IVD) rapid test kits and revolutionary customized reagent kits to all parts of the world.
- Personal Healthcare Devices: thermo-meters, blood pressure monitors, and blood glucose meters. Pregnancy & Fertility Tests.
- For more information about our products or services, please contact us!
New generation therapy
Bel Group is at the forefront of innovative healthcare solutions, working with our partner in East Asia and Europe on the development of new-generation therapy – Dendritic Cell Therapy (DCT). This advanced therapy harnesses the body’s immune system to fight diseases, including cancer, by utilizing dendritic cells to present antigens to the immune system, thereby stimulating a targeted immune response. We bring this cutting-edge as Cancer Immunotherapy to patients worldwide.
- Dendritic Cell Therapy (DCT)
- We work closely with partners hospitals in Spain, Germany, and Switzerland to ensure the highest standards of treatment and care.
- Our vision is to create a healthier world by providing accessible and affordable healthcare solutions. We aim to be a trusted partner in the global healthcare market, known for our integrity, innovation, and excellence.
